Restructuring and Asset Impairment Charges |
3 Months Ended | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||
Restructuring and Asset Impairment Charges | |||||||||||||||||||||
Restructuring and Asset Impairment Charges | 12. Restructuring and Assets Impairment Charges In July 2024, the Company’s Board of Directors approved a streamlined operating plan that included a reduction in the Company’s workforce by approximately 80%. During the three months ended March 31, 2025, substantially all of the Company’s remaining employees were terminated. Employees were entitled to receive severance payments and Company-funded medical insurance for a specific time. During the year ended December 31, 2024, the Company recognized $7.0 million of charges for severance and related benefits. The following is a summary of the activity for accrued severance costs for the three months ended March 31, 2025:
The accrued severance liability of $1.7 million is payable within the next twelve months and has been included in accrued expenses on the balance sheet as of March 31, 2025. |